Last reviewed · How we verify

NCT04962932

Internet-delivered Cognitive Behavior Therapy Compared to Stress Management for Atrial Fibrillation

Completed NA Last updated 11 October 2023
What this trial tests

NA trial testing Internet-deliviered exposure-based CBT in Atrial Fibrillation in 206 participants. Completed in 5 October 2023.

Timeline
13 August 2021
Primary endpoint
31 March 2023
5 October 2023

Quick facts

Lead sponsorKarolinska Institutet
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment206
Start date13 August 2021
Primary completion31 March 2023
Estimated completion5 October 2023
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 18 to 75, any sex, with Atrial Fibrillation or Arrythmia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate if internet- delivered cognitive behavior therapy (CBT), based on exposure principles and behavioral activation, improves QoL and symptom burden in patients with symptomatic atrial fibrillation (AF), controlling for expectancy of improvement and attention from a caregiver, using an active control group (stress management). The study will include 260 patients with symptomatic AF despite optimal medical treatment in accordance with current guidelines.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04962932.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing